Aspirin shows promise for colon cancer patients
Aug. 11, 2009
CHICAGO (AP) - Score another win for the humble aspirin. A study
suggests colon cancer patients who took the dirt-cheap wonder drug
reduced their risk of death from the disease by nearly 30 percent. Aspirin
already is recommended for preventing heart attacks and strokes, along
with its traditional use for relief of minor aches and pains. Its merit in colon
cancer prevention has been tempered by its side effects, bleeding from
irritation of the stomach or intestines.